Histoplasmosis pathophysiology: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(5 intermediate revisions by 3 users not shown)
Line 2: Line 2:
{{Histoplasmosis}}
{{Histoplasmosis}}


{{CMG}}
{{CMG}}; {{AE}}  {{AKI}}


==Overview==
==Overview==
Line 9: Line 9:
==Pathophysiology==
==Pathophysiology==
===Reservior===
===Reservior===
Soil is the reservior for [[Histoplasma capsulatum|histoplasma]] microconidia, particularly when heavily contaminated with bird or bat droppings.
* Soil is the reservior for [[Histoplasma capsulatum|histoplasma]] microconidia, particularly when heavily contaminated with bird or bat droppings.


===Transmission===
===Transmission===
Line 17: Line 17:
===Pathogenesis===
===Pathogenesis===
*In majority of the patients the infection is asymtomatic and resolves with host's [[immune response]]. In few patients inhalation of large amount of [[inoculum]] can result in an acute pulmonary infection with symptoms resembling [[pneumonia]].<ref name="pmid27882146">{{cite journal| author=Zhu C, Wang G, Chen Q, He B, Wang L| title=Pulmonary histoplasmosis in a immunocompetent patient: A case report and literature review. | journal=Exp Ther Med | year= 2016 | volume= 12 | issue= 5 | pages= 3256-3260 | pmid=27882146 | doi=10.3892/etm.2016.3774 | pmc=5103774 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27882146  }} </ref>
*In majority of the patients the infection is asymtomatic and resolves with host's [[immune response]]. In few patients inhalation of large amount of [[inoculum]] can result in an acute pulmonary infection with symptoms resembling [[pneumonia]].<ref name="pmid27882146">{{cite journal| author=Zhu C, Wang G, Chen Q, He B, Wang L| title=Pulmonary histoplasmosis in a immunocompetent patient: A case report and literature review. | journal=Exp Ther Med | year= 2016 | volume= 12 | issue= 5 | pages= 3256-3260 | pmid=27882146 | doi=10.3892/etm.2016.3774 | pmc=5103774 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27882146  }} </ref>
*The [[Cell-mediated immunity|cell mediated]] [[immune response]] is by the [[T-lymphocytes]] which recognize the [[organism]] and induce the release of [[cytokines]] such as [[Tumour necrosis factor|tumor necrosis factor]] alpha and [[Interferon-gamma|interferon gamma]] providing protection aganist re-infection.
*The [[Cell-mediated immunity|cell mediated]] [[immune response]] is by the [[T-lymphocytes]] which recognize the [[organism]] and induce the release of [[cytokines]] such as [[Tumour necrosis factor|tumor necrosis factor]] alpha and [[Interferon-gamma|interferon gamma]] providing protection aganist re-infection.<ref name="pmid26059620">{{cite journal| author=Horwath MC, Fecher RA, Deepe GS| title=Histoplasma capsulatum, lung infection and immunity. | journal=Future Microbiol | year= 2015 | volume= 10 | issue= 6 | pages= 967-75 | pmid=26059620 | doi=10.2217/fmb.15.25 | pmc=4478585 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26059620  }}</ref>
*The release of [[cytokines]] activates [[macrophages]], inhibiting the growth of the [[fungus]] and limit its spread to the surrounding tissue. This results in the formation of a [[granuloma]] where in the fungus is present in a nonviable state for life.
*The release of [[cytokines]] activates [[macrophages]], inhibiting the growth of the [[fungus]] and limit its spread to the surrounding tissue. This results in the formation of a [[granuloma]] where in the fungus is present in a nonviable state for life.
*In patients with [[immunosuppression]], they are unable to mount an adequate [[T cell|T-cell]] mediated [[immune response]] resulting in uncontrolled growth of the [[organism]] with spread to the surrounding tissue and increasing the [[morbidity]] and [[mortality]] of the infection.<ref name="pmid22092757">{{cite journal| author=Edwards JA, Rappleye CA| title=Histoplasma mechanisms of pathogenesis--one portfolio doesn't fit all. | journal=FEMS Microbiol Lett | year= 2011 | volume= 324 | issue= 1 | pages= 1-9 | pmid=22092757 | doi=10.1111/j.1574-6968.2011.02363.x | pmc=3228276 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22092757  }} </ref>  
*In patients with [[immunosuppression]], they are unable to mount an adequate [[T cell|T-cell]] mediated [[immune response]] resulting in uncontrolled growth of the [[organism]] with spread to the surrounding tissue and increasing the [[morbidity]] and [[mortality]] of the infection.<ref name="pmid22092757">{{cite journal| author=Edwards JA, Rappleye CA| title=Histoplasma mechanisms of pathogenesis--one portfolio doesn't fit all. | journal=FEMS Microbiol Lett | year= 2011 | volume= 324 | issue= 1 | pages= 1-9 | pmid=22092757 | doi=10.1111/j.1574-6968.2011.02363.x | pmc=3228276 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22092757  }} </ref>  
*Primary cutaneous histoplasmosis and solid organ donor-derived histoplasmosis have been observed although extremely uncommon.<ref name=cdc3>Information for Healthcare Professionals about Histoplasmosis. Centers for Disease Control and Prevention. 2015. Available at: http://www.cdc.gov/fungal/diseases/histoplasmosis/health-professionals.html. Accessed February 2, 2016.</ref>
*Primary cutaneous histoplasmosis and solid organ donor-derived histoplasmosis have been observed although extremely uncommon.<ref name="cdc3">Information for Healthcare Professionals about Histoplasmosis. Centers for Disease Control and Prevention. 2015. Available at: http://www.cdc.gov/fungal/diseases/histoplasmosis/health-professionals.html. Accessed February 2, 2016.</ref><ref name="pmid27512207">{{cite journal| author=Raina RK, Mahajan V, Sood A, Saurabh S| title=Primary Cutaneous Histoplasmosis in an Immunocompetent Host from a Nonendemic Area. | journal=Indian J Dermatol | year= 2016 | volume= 61 | issue= 4 | pages= 467 | pmid=27512207 | doi=10.4103/0019-5154.185748 | pmc=4966422 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27512207  }} </ref>


===Microscopic pathology===
===Microscopic pathology===
Line 32: Line 32:
[[Category:Fungal diseases]]
[[Category:Fungal diseases]]
[[Category:Rat carried diseases]]
[[Category:Rat carried diseases]]
[[Category:Emergency mdicine]]
[[Category:Disease]]
[[Category:Up-To-Date]]
[[Category:Infectious disease]]
[[Category:Pulmonology]]
[[Category:Gastroenterology]]

Latest revision as of 22:11, 29 July 2020

Histoplasmosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Histoplasmosis from other Diseases

Epidemiology and Demographics

Screening

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Histoplasmosis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Histoplasmosis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Histoplasmosis pathophysiology

CDC on Histoplasmosis pathophysiology

Histoplasmosis pathophysiology in the news

Blogs on Histoplasmosis pathophysiology

Directions to Hospitals Treating Histoplasmosis

Risk calculators and risk factors for Histoplasmosis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aravind Kuchkuntla, M.B.B.S[2]

Overview

Histoplasmosis is typically acquired via inhalation of airborne microconidia, often after disturbance of contaminated material in the soil. In majority of the patients the infection is asymtomatic and resolves with host's immune response. In few patients inhalation of large amount of inoculum can result in an acute pulmonary infection with symptoms resembling pneumonia. In patients with immunosuppression, they are unable to mount an adequate T-cell mediated immune response resulting in uncontrolled growth of the organism with spread to the surrounding tissue and increasing the morbidity and mortality of the infection.

Pathophysiology

Reservior

  • Soil is the reservior for histoplasma microconidia, particularly when heavily contaminated with bird or bat droppings.

Transmission

  • The areas contaminated with histoplasma microconidia are called microfoci and disturbance of these microfoci will result in exposure to them.
  • The activities which expose the patient to histoplasma microconidia include farming, exposure to chicken coops or caves and sites where black birds have roosted.
  • Histoplasmosis is typically acquired via inhalation of airborne microconidia, often after disturbance of contaminated material in the soil.

Pathogenesis

Microscopic pathology

References

  1. Zhu C, Wang G, Chen Q, He B, Wang L (2016). "Pulmonary histoplasmosis in a immunocompetent patient: A case report and literature review". Exp Ther Med. 12 (5): 3256–3260. doi:10.3892/etm.2016.3774. PMC 5103774. PMID 27882146.
  2. Horwath MC, Fecher RA, Deepe GS (2015). "Histoplasma capsulatum, lung infection and immunity". Future Microbiol. 10 (6): 967–75. doi:10.2217/fmb.15.25. PMC 4478585. PMID 26059620.
  3. Edwards JA, Rappleye CA (2011). "Histoplasma mechanisms of pathogenesis--one portfolio doesn't fit all". FEMS Microbiol Lett. 324 (1): 1–9. doi:10.1111/j.1574-6968.2011.02363.x. PMC 3228276. PMID 22092757.
  4. Information for Healthcare Professionals about Histoplasmosis. Centers for Disease Control and Prevention. 2015. Available at: http://www.cdc.gov/fungal/diseases/histoplasmosis/health-professionals.html. Accessed February 2, 2016.
  5. Raina RK, Mahajan V, Sood A, Saurabh S (2016). "Primary Cutaneous Histoplasmosis in an Immunocompetent Host from a Nonendemic Area". Indian J Dermatol. 61 (4): 467. doi:10.4103/0019-5154.185748. PMC 4966422. PMID 27512207.